meet vanda We are using pharmacogenetics to match promising molecules to the right patients. So selecting the right medicine will be easier, thanks to our more personal approach.

Vanda possesses several compounds that may offer meaningful benefits to patients, clinicians, and payors. Iloperidone (phase III completed) Iloperidone is a 5HT2/D2 antagonist ...

Get the latest on Vanda Pharmaceuticals Inc. (VNDA) including stock quotes, interactive charts, up to date news, high quality discussion groups and more on Google Finance.

Start research for Vanda Pharmaceuticals Inc VNDA.O stock data, including stock quotes, stock trading and stock prices at Reuters.com. Read Vanda Pharmaceuticals Inc VNDA.O ...

Read the Vanda Pharmaceuticals Inc VNDA.O company profile at Reuters.com. ... Vanda Pharmaceuticals Inc., incorporated in 2002, is a biopharmaceutical company focused on the ...

VANDA PHARMACEUTICALS INC. ANNOUNCES INITIAL PUBLIC OFFERING OF 5,750,000 SHARES OF COMMON STOCK AT $10.00 PER SHARE PR Newswire, April 12, 2006 Vanda Pharmaceuticals Inc ...

Find financial news, press releases and podcasts for Vanda Pharmaceuticals, Inc. (VNDA) on Boston.com

Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone. - ROCKVILLE, Md., July 28 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq:

Vanda Pharmaceuticals to Present at the FBR Capital Markets 12th Annual Spring Investor Conference. - ROCKVILLE, Md., May 22 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc ...

Vanda Pharmaceuticals, Inc. to Present at the FBR Capital Markets 12th Annual Spring Investor Conference; Presentation Will be Webcast Live and Archived on Company's Website 5 ...

Vanda Pharmaceuticals, Inc. Reports Second Quarter 2008 Results 8/6/2008. ROCKVILLE, Md., Aug. 5 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. , a biopharmaceutical ...

Form (Filer) Received ( Period) 4: VANDA PHARMACEUTICALS INC. (POLYMEROPOULOS MIHAEL HRISTOS) 08/12/08 (08/11/08)

MarketWatch, a leading publisher of business and financial news, offers users up-to-the minute news, investment tools, and subscription products. ...

The article about this company has not been written yet. You could be the first person to write about this company?it's a sure thing that you'll... ... The article about this ...

Vanda Pharmaceuticals Inc. Profile ... Vanda Pharmaceuticals Inc. News and overview for Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Hires Chief Commercial Officer ... PR Newswire | 299 days 7 minutes ago. Vanda Pharmaceuticals Hires Chief Commercial Officer

Company: Vanda Pharmaceuticals Starting stock price: $24.83 Ending stock price: $6.88 Percent Change: -72.29% Details: Vanda Pharmaceuticals has three Read more...

vanda pharmaceuticals announces pricing of follow-on offering of 3,800,000 shares of common stock

vanda pharmaceuticals' vec-162 demonstrates positive results in a phase iii transient insomnia clinical trial

Up to date analysis of Vanda Pharmaceuticals, Inc. (VNDA) and its stock by hedge fund managers and industry experts. Find out what Vanda Pharmaceuticals, Inc. is saying about its ...

Customer Service: 800-369-2834 or e-mail onlinesupport@barrons.com Mon.-Fri., 7am to 10pm ET & Sat., 8am to 3pm. Dialing from outside the U.S.? Print Subscribers and Students ...

Vanda Pharmaceuticals to Announce Second Quarter 2008 Financial Results on August 5, 2008

Vanda Pharmaceuticals Announces Receipt of Not Approvable Letter From FDA for Iloperidone

Vanda Pharmaceuticals narrows losses ... Days after getting a drug rejection letter from federal regulators that sent its stock price plummeting, Vanda Pharmaceuticals Inc ...

Vanda Pharmaceuticals narrows losses ... Days after getting a drug rejection letter from federal regulators that sent its stock price plummeting, Vanda Pharmaceuticals Inc ...

TradingMarkets News for VNDA - Vanda Pharmaceuticals Hits Monthly High ... For full details on Vanda Pharmaceuticals Inc (VNDA) click here. Vanda Pharmaceuticals Inc (VNDA) has ...

Vanda Pharmaceuticals narrows losses ... Days after getting a drug rejection letter from federal regulators that sent its stock price plummeting, Vanda Pharmaceuticals Inc ...

Obama deflects Swift Boat question Shearer mines gold with off-air video clips U.S ... All: u.s. world: politics: business: sports: entertainment: sci/tech: health: odd: video ...

Vanda Pharmaceuticals Reports Second Quarter 2008 Results. - ROCKVILLE, Md., Aug. 5 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA - News), a biopharmaceutical ...

Market Intelligence Center News On Symbol(VNDA) On Thursday, June 26, 2008 10:37 AM ... Vanda Pharmaceuticals Inc. opened at 5.03. So far today, the stock has hit a low of 4.85 and ...